Related Experiment Video

Updated: Aug 15, 2026

Single Myofiber Isolation and Culture from a Murine Model of Emery-Dreifuss Muscular Dystrophy in Early Post-Natal Development
08:07

Single Myofiber Isolation and Culture from a Murine Model of Emery-Dreifuss Muscular Dystrophy in Early Post-Natal Development

Published on: July 1, 2020

Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular

W H Raharjo1, P Enarson, T Sullivan

  • 1Department of Cell Biology and Anatomy, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada.

Journal of Cell Science
|January 17, 2002
PubMed

Insights

Mutations in nuclear lamins A and C cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy by disrupting nuclear structure. Other mutations, like those for familial partial lipodystrophy, do not affect lamin assembly.

Area of Science:

  • Cell Biology
  • Genetics
  • Molecular Biology

Background:

  • Nuclear lamins A and C are crucial structural proteins of the nuclear lamina.
  • Mutations in the Lmna gene are associated with several human diseases, including cardiomyopathies and muscular dystrophies.
  • Understanding how specific mutations affect lamin assembly and nuclear organization is key to understanding disease mechanisms.

Purpose of the Study:

  • To investigate the impact of disease-associated lamin A/C mutations on protein assembly and localization.
  • To compare the cellular effects of mutations causing dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy with those causing familial partial lipodystrophy.
  • To elucidate the role of nuclear structural defects in the pathogenesis of laminopathies.

Main Methods:

  • Expression of wild-type and mutant lamin A/C alleles in HeLa cells and Lmna null mouse fibroblasts.
  • Analysis of lamin assembly properties and localization within the nuclear lamina.
  • Assessment of the localization of emerin, an inner nuclear membrane protein, in the presence of mutant lamins.

Main Results:

  • Mutations causing dilated cardiomyopathy (L85R, N195K) and Emery-Dreifuss muscular dystrophy (L530P) altered lamin A/C assembly and caused partial emerin mislocalization.
  • These disease-associated mutant lamins interfered with the assembly of endogenous lamins, potentially altering nuclear periphery organization.
  • A mutation linked to familial partial lipodystrophy (R482W) did not affect lamin A/C targeting or assembly, behaving similarly to wild-type lamins.

Conclusions:

  • Nuclear structural defects resulting from specific lamin A/C mutations may contribute to the development of dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy.
  • The distinct cellular behaviors of different Lmna mutations highlight the specific mechanisms underlying various laminopathies.
  • These findings underscore the importance of nuclear lamina integrity in preventing disease.

More Related Videos

Preparation of 3D Decellularized Matrices from Fetal Mouse Skeletal Muscle for Cell Culture07:44

Preparation of 3D Decellularized Matrices from Fetal Mouse Skeletal Muscle for Cell Culture

Published on: March 3, 2023

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...